Non-life legacy deals up 28% for Q1 after Aspen deal: PwC
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Email
  • Free Trial
  • Log in

Non-life legacy deals up 28% for Q1 after Aspen deal: PwC

Luke Harrison
16 May 2022
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Email
business background of businessman having handshake

The total value of executed deals in the non-life legacy market for Q1 2022 rose 28% to $4.2bn, compared to $3.3bn during the same period last year, according to a PwC report.

The report on run-off transactions shows that despite a marginal drop in dealflow to 11 from 12 deals in the first quarter of 2021, the market’s appetite to execute on high-value legacy portfolios appears to remain robust.

As

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News London market Legacy Aspen
Luke_Harrison.png
Luke Harrison
Reporter
Gift this article